Furthermore, the clinically relevant data presented showed that patients with HCC and high tumor NXF3 expression levels had decreased OS times and earlier TTR compared with those of patients with low tumor NXF3 expression levels. Here, NXF3 is linked to hepatocellular carcinoma.